Discover 884 paid clinical trials in Daytona Beach, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Location: Orlando FL, Safety Harbor FL, Atlanta GA,
Sponsor: Medtronic Vascular
Sex: All
Age: 18 - 70+
Code: NCT06907147
Recruiting
Regeneration of Acutely Injured Nerves With Temporary Electrical Stimulation
for
Nerve Injury
Location: Orlando FL, Gainesville FL, New Orleans LA, Hamilton,
Sponsor: Epineuron Technologies Inc.
Sex: All
Age: 18 - 65
Code: NCT05721261
Recruiting
Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without Center-Involved Diabetic Macular Edema
for
Diabetic Retinopathy
Location: Orlando FL, Lakeland FL, Charleston SC, Augusta GA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07592273
Phase 2, Phase 3, Recruiting
Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)
Location: Orlando FL, Jacksonville FL, Fort Lauderdale FL,
Sponsor: EyeBiotech Ltd.
Sex: All
Age: 18+
Code: NCT07205887
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Orlando FL, Winter Haven FL, Tampa FL, Bayonet Point FL,
Sponsor: Apellis Pharmaceuticals, Inc.
Sex: All
Age: 60+
Code: NCT07215390
Phase 2, Recruiting
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Location: Orlando FL, Tampa FL, Hudson FL, St. Petersburg FL,
Sponsor: 4D Molecular Therapeutics
Sex: All
Age: 50+
Code: NCT07064759
Phase 3, Recruiting
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer
for
Endometrial Neoplasms, Endometrial Cancer
Location: Orlando FL, Jupiter FL, Nashville TN, Chesapeake VA,
Sponsor: Pfizer
Sex: Female
Age: 18+
Code: NCT07578649
Phase 3, Recruiting
Randomized Trial of Percutaneous vs. Endoscopic Gallbladder Drainage
A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05)
for
Ovarian Cancer, Peritoneal Cancer, Fallopian Tube Cancer
Location: Orlando FL, Fort Worth TX, Fountain Valley CA
Sponsor: Merck Sharp & Dohme LLC
Sex: Female
Age: 18+
Code: NCT07743164
Phase 3, Recruiting
New
Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Orlando FL, West Columbia SC, Columbus MS,